Advertise | About Us | Contact Us

Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Novartis to Invest US$23 Billion to State-of-the-Art Manufacturing and R&D Facility in USA

Novartis has announced plans to invest US$23 billion over the next five years to expand its manufacturing and RD footprint across the United States

Woodstock Sterile Solutions Invests US$8 million for State-of-the-Art Bottle Packaging Line Facility in USA

Woodstock Sterile Solutions plans to invest US$8 million to open a new stateoftheart facility in the Woodstock, Illinois

Johnson & Johnson Invests US$2 Billion in State-of-the-Art Biologics Facility in North Carolina, USA

Johnson Johnson plans to invest US$2 billion to develop a new biologics manufacturing facility in Wilson, North Carolina, USA

Curia Invests US$200 Million to Expand Facilities in the UK and USA

Curia is investing US$200 million to expand its sterile fillfinish facilities in Glasgow, UK, and Albuquerque, NM, USA

CordenPharma Constructs New Peptide Manufacturing Facility in Switzerland

CordenPharma is investing over US$540 million 500 million to construct a new peptide manufacturing facility in Muttenz, Switzerland The facility, located at Getec Park near Basel, is designed for small, medium, and largescale peptide production

NJEDA and Coriell Institute for Medical Research Invests US$41 million for State-of-the-Art Innovation Centre in UK

The New Jersey Economic Development Authority NJEDA and the Coriell Institute for Medical Research plan to invest US$41 million in the establishment of a stateoftheart Strategic Innovation Centre SIC in Camden

Endo Plans to Open New Manufacturing Facility in India

Endo, Inc announces its plans to open a new aseptic manufacturing facility in Indore, India This cuttingedge 20,000squarefoot facility is specifically designed for the aseptic manufacturing of sterile injectable products